Mobile App Click here to download our Mobile App for iOS or Android
Not a member? Sign up for free!

Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

Webinar | March 15, 2017 12:00 pm to 12:45 pm EST
You must be logged in to register for PsychU events. Log In

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU


Virtual Forum: Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

Location: Online Via

Description: While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this virtual forum, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP will discuss several considerations in optimizing the treatment of patients with schizophrenia. The speakers will explore the consequences of relapse for patients with schizophrenia who discontinue medications, will discuss patient- and system-level indicators that may aid in the identification of those patients at a high potential for discontinuing antipsychotic therapy, and will address how physicians can use basic pharmacogenomics to guide dosing of antipsychotics. The virtual forum will conclude with time for questions from the audience.

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

View Flyer (PDF)

Event Speakers

Henry A. Nasrallah, MD
Featured Speaker

Dr. Nasrallah is the Sydney W. Souers Professor and Chair of the Department of Psychiatry at Saint Louis University (St. Louis, MO), and he is the Editor-in-Chief of Schizophrenia Research and Current Psychiatry. He is a widely recognized neuropsychiatrist, educator, and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the National Institutes of Health, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University to chair the integrated Department of Neurology and Psychiatry.

Dr. Nasrallah earned his MD from the American University of Beirut, School of Medicine (Beirut, Lebanon).

Roger Sommi, PharmD, BCPP, FCCP
Featured Speaker

Dr. Roger Sommi is the Associate Dean at the UMKC School of Pharmacy at The University of Missouri, the Vice Chair in the Division of Pharmacy Practice and Administration, and a Professor of Pharmacy Practice and Psychiatry.

Walter Lawhorn, PharmD

Walter Lawhorn, PharmD, serves as a Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. His clinical areas of expertise include: clinical pharmacy, HIV / AIDS research, medical information, literature searching and analysis, clinical trial study design, schizophrenia, and bipolar disorder.

Walter attended Valdosta State University in Valdosta, Georgia; and Mercer University School of Pharmacy in Atlanta, Georgia.

The registration for this event is now closed. For more information about our live event registration process, please read the Live Event Eligibility Requirements